NEW YORK (GenomeWeb) – Vermillion reported after the close of the market on Monday a more-than-threefold increase in its first quarter revenues. 

For the three months ended March 31, the Austin, Texas-based bioanalytical solutions firm said that total revenues rose to $951,000 from $305,000 in the year-ago quarter. 

The firm notched $635,000 in product revenues, up from $191,000 in Q1 2014, and $316,000 in license revenues, up from $114,000 a year ago. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.